Talk:Georgina Long

Connected contributor

I am requesting edits for Prof Georgina Long AO, Co-Medical Director of Melanoma Institute Australia. I am an employee of Melanoma Institute Australia. Mia Varley (talk) 05:32, 12 January 2021 (UTC)

Edit Request - please confirm previous request

• Information to be added is detailed below (plus in brackets I have put references supporting change)

I added the two awards to AWARDS SECTION on 26 Nov. They still appear now, but please confirm that these are accepted to remain.

2020 — Clarivate analytics Highly Cited Researchers List. OR 2019 — Clarivate analytics Highly Cited Researchers List.

Mia Varley (talk) 06:08, 12 January 2021 (UTC)

Decisions are never unalterable. WhatamIdoing (talk) 20:24, 13 February 2021 (UTC)

Request for edit - Update to introduction 1

• Information to be added or removed:

URL References supporting change are included)

1. Please update the introduction paragraph so it reads as follows This fully replaces the first paragraph of the current introduction.

Professor Georgina Long AO, BSc PhD MBBS FRACP FAHMS, is Co-Medical Director of Melanoma Institute Australia (MIA), and Chair of Melanoma Medical Oncology and Translational Research at MIA and Royal North Shore Hospital, The University of Sydney. She leads an extensive clinical trials team and laboratory at MIA, with a focus on targeted therapies and immuno-oncology in melanoma. She is principal investigator on phase I, II and III clinical trials in adjuvant and metastatic melanoma, including trials in patients with active brain metastases. She is the chief investigator on NHMRC funded research into the molecular biology of melanoma, with a particular interest in clinical and tissue biomarker correlates of systemic therapy sensitivity and resistance. In recognition of her ground-breaking research and work, Professor Long was appointed as an Officer of the Order of Australia (2020) and has received several awards, including the Research Australia, GSK Research Excellence Award (2018) and prestigious Sir Zelman Cowen Universities Fund Prize for Discovery in Medical Research (2016). She has a number of CINSW Premiers Awards, including; the Outstanding Cancer Researcher (2018), the Excellence in Translational Cancer Research Award (2017), the Wildfire Award for the most highly-cited, original, peer-reviewed article published (2011, 2014, 2016 & 2017), and in 2013 she was named the Outstanding Cancer Research Fellow. .

Mia Varley (talk) 07:45, 12 January 2021 (UTC)

Request for edit - Update to introduction 2

• Information to be added or removed:

URL References supporting change are included)

2. Please add paragraph to introduction:

Long's h-index is 100 and in October 2020 she was ranked the world's 5th, and Australia's 1st melanoma expert. &

Mia Varley (talk) 07:45, 12 January 2021 (UTC)

I am declining this request because:

• It is promotional content.
• It is poorly sourced.
  • The scholar.google.com link is a WP:PRIMARY source and does not indicate that this number is meaningful. The expertscape.com link goes to a website written by two men: a doctor who once had trouble finding a neurologist when his uncle was sick in another city, and a marketing guy. This will never be a reliable source.
• It is poorly written, so that the reader will not understand what these claims mean.
  • For example: Is an H-index of 100 a good thing or a bad thing? No context is provided.
  • For example: What does it mean to be 'ranked the world's 5th melanoma expert'? According to whom? And how did they decide that? Does that mean that she writes more papers, treats more people, cures more patients, gets more positive reviews for her bedside manner? And what do we do if another source says she's the third expert, or the tenth, or not an expert at all?
• This type of content is inherently inappropriate for an encyclopedia. It cannot be 'fixed up' in a way that will make it suitable.

WhatamIdoing (talk) 20:37, 13 February 2021 (UTC)

Request for edit - Update to introduction 3

• Information to be added or removed:

URL References supporting change are included)

3. Please replace the 3rd paragraph of intro:

Professor Long is the author of over 320 peer-reviewed publications in melanoma clinical and translational research, including the New England Journal of Medicine, The Lancet, The Lancet Oncology, Science, Nature, Journal of Clinical Oncology and Cancer Discovery. OR . Professor Long has presented her work at international conferences and meetings on more than 180 occasions.. Long is the first woman and the first Australian to be President of the Society for Melanoma Research from 2018 to 2020, ref>https://www.societymelanomaresearch.org/about/officers</ref>, is a member and chair of the ESMO (2017-2020) Scientific Committee for Melanoma/Skin Cancer and a member and Chair of the ASCO (2015-2017) Scientific Committee for Melanoma/Skin Cancer. She is medical oncology lead for the Australian Melanoma Management Guidelines Committee , is on editorial boards of several high impact journals, and is a member of the Melanoma Expert Panel for AJCC Cancer Staging System 8th edition.

Mia Varley (talk) 07:45, 12 January 2021 (UTC)

Edit Request - please edit 'Early life and career' section

Please insert a second paragraph between the 2 paragraphs in the 'Early life and career section'

Professor Long was awarded the University Medal in Organic Chemistry. She subsequently completed her PhD in Chemistry in the field of anti-cancer agents and their binding to DNA. She then moved to the USA to take up a Fulbright Postdoctoral Fellowship at Scripps Research Institute, exploring nanotechnology in cancer treatment, before returning to Australia to complete her MBBS (Hons). Professor Long became a Fellow of the Australasian College of Physicians in January 2008, specialising in medical oncology.

Mia Varley (talk) 08:13, 12 January 2021 (UTC)